Johnson & Johnson and AbbVie bought a combined $55m of stock as the biopharmaceutical company, already listed in Europe, went public on Nasdaq.

North West Fund returns for second six-figure investment into Liverpool canine-focused 3D printer spin-out Fusion Implants.

Bank of Ireland Seed and Early Stage Fund plans to divest 25% of its portfolio in the next year, beginning with medical device developer NeoSurgical.

Goldsmiths University partners Tungsten on joint AI research and development centre.

MPM Capital has closed an oversubscribed $400m life sciences venture fund that counts Novartis and Astellas among its limited partners.

The partnership, formed to develop immuno-oncology drugs, will include a $30m equity investment in BioNTech subsidiary Cell & Gene Therapies.

Pfizer also picked up the right to acquire AbbVie-backed AM-Pharma, the developer of a treatment for acute kidney disease, in a deal that could eventually total $600m.